Social and economic burden of breast cancer in the North East region of Bulgaria.

Expert Rev Pharmacoecon Outcomes Res

Department of Organisation and Economics of Pharmacy, Faculty of Pharmacy, Medical University - Sofia, Sofia, Bulgaria.

Published: December 2021

Breast cancer is one of the most common malignancies among women and significantly worsens physical, mental and social functioning. The aim is to evaluate the social and economic burden of treatment strategies for breast cancer in the North East region of Bulgaria. A retrospective, observational, population-based study among patients with breast cancer was performed. Patient characteristics, treatment patterns, and costs were assessed during a four-year period (2016-2019). Disability-adjusted life years (DALYs) were calculated to estimate the social burden. Approximately 99% of patients ( = 1,373) were female and the mean age at diagnosis was 60.6 years. The total economic burden of breast cancer during the time of the study was estimated to be 21,076,809.12 BGN where the direct costs were equal to 19,634,509.67 BGN and the total indirect costs due to premature death amounted to 1,442,299.45 BGN. Total DALYs were 110.56 for all patients corresponding to 1,898,340.80 BGN. This study demonstrates the significant social and economic burden of breast cancer as further, more comprehensive regional and national-based studies related to the total economic burden of breast cancer are required.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2021.1947247DOI Listing

Publication Analysis

Top Keywords

breast cancer
28
economic burden
20
burden breast
16
social economic
12
cancer north
8
north east
8
east region
8
region bulgaria
8
total economic
8
bgn total
8

Similar Publications

Aim: Breast cancer is the second most common cancer among women and the leading cause of cancer-related mortality in this population. Numerous factors have been identified as either risk factors or protective factors for breast cancer. However, the role of Vitamin D (Vit.

View Article and Find Full Text PDF

Purpose: To investigate the effects of compression therapy combined with exercise for cancer patients (EXCAP) in patients with peripheral neuropathy caused by breast cancer chemotherapy.

Methods: Overall, 108 patients with peripheral neuropathy after chemotherapy for breast cancer were randomly divided into the control group (routine nursing), experimental group 1 (compression therapy), and experimental group 2 (compression therapy and EXCAP). The National Institute of Cancer Drug Toxicity Rating Scale and the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool were assessed and compared between groups.

View Article and Find Full Text PDF

Purpose: Over 50% of households in the United States have at least one musician-many musicians are also breast cancer survivors. This group has not been well studied, and given the level of fine sensory-motor skill required for musicianship, we hypothesized that musicians experience unique manifestations of breast cancer treatment toxicities.

Methods: A nine-item Musical Toxicity Questionnaire (MTQ) was distributed to patients who had consented to participate in the Mayo Clinic Breast Cancer Registry.

View Article and Find Full Text PDF

Rare Indocyanine-Induced Anaphylactic Shock During Deep Inferior Epigastric Artery Perforator Breast Reconstruction: A Case Report.

Ann Plast Surg

February 2025

From the Department of Plastic and Reconstructive Surgery, Ewha Womans University College of Medicine, Mokdong Hospital, Seoul, Republic of Korea.

Indocyanine green (ICG) is a water-soluble green substance that is detectable through infrared cameras and emits greenish light. Approved for medical use in the 1950s, ICG has gained prominence as a real-time visualization tool. Widely recognized as a generally safe substance, ICG is applied in diverse fields.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!